Anti-TNF-alpha treatment strategies: results and clinical perspectivesD'HAENS, G.Gastroentérologie clinique et biologique. 2009, Vol 33, issn 0399-8320, S209-S216, SUP3Article

The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort studyMARCHAL, L; D'HAENS, G; RUTGEERTS, P et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 7, pp 749-754, issn 0269-2813, 6 p.Article

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's diseaseRUTGEERTS, P; D'HAENS, G; SCHAIBLE, T. F et al.Gastroenterology (New York, NY. 1943). 1999, Vol 117, Num 4, pp 761-769, issn 0016-5085Article

Appendectomy protects against ulcerative colitisRUTGEERTS, P; D'HAENS, G; HIELE, M et al.Gastroenterology (New York, NY. 1943). 1994, Vol 106, Num 5, pp 1251-1253, issn 0016-5085Article

Adalimumab for the treatment of fistulas in patients with Crohn's diseaseCOLOMBEL, J.-F; SCHWARTZ, D. A; KENT, J. D et al.Gut. 2009, Vol 58, Num 7, pp 940-948, issn 0017-5749, 9 p.Article

Atypical symptoms of GORD in Belgium : Epidemiological features, current management and open label treatment with 40 mg esomeprazole for one monthLOUIS, E; JORISSEN, P; BASTENS, B et al.Acta gastro-enterologica belgica (English ed.). 2006, Vol 69, Num 2, pp 203-208, issn 1784-3227, 6 p.Article

Once daily MMX mesalazine for the treatment of mild-to- moderate ulcerative colitis : a phase II, dose-ranging studyD'HAENS, G; HOMMES, D; JOSEPH, R et al.Alimentary pharmacology & therapeutics. 2006, Vol 24, Num 7, pp 1087-1097, issn 0269-2813, 11 p.Article

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease : A European multicenter trialD'HAENS, G; VAN DEVENTER, S; VAN HOGEZAND, R et al.Gastroenterology (New York, NY. 1943). 1999, Vol 116, Num 5, pp 1029-1034, issn 0016-5085Article

Lymphocytic colitis : a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitisBAERT, F; WOUTERS, K; D'HAENS, G et al.Gut. 1999, Vol 45, Num 3, pp 375-381, issn 0017-5749Article

Association of baseline C-reactive protein and prior anti-tumor necrosis factor therapy with need for weekly dosing during maintenance therapy with adalimumab in patients with moderate to severe Crohn's diseaseSANDBORN, W. J; COLOMBEL, J.-F; D'HAENS, G et al.Current medical research and opinion. 2013, Vol 29, Num 5, pp 483-493, issn 0300-7995, 11 p.Article

An uncommon cause of visceral arterial embolism in patients presenting with acute abdominal pain: a report of 2 casesULENAERS, M; BUCHEL, O. C; VAN OLMEN, A et al.Acta gastro-enterologica belgica (English ed.). 2010, Vol 73, Num 1, pp 55-60, issn 1784-3227, 6 p.Article

Quality assurance and recommendations for quality assessment of screening colonoscopy in BelgiumMACKEN, E; MOREELS, T; HOSTE, P et al.Acta gastro-enterologica belgica (English ed.). 2009, Vol 72, Num 1, pp 17-25, issn 1784-3227, 9 p.Article

Patchy cecal inflammation associated with distal ulcerative colitis : A prospective endoscopic studyD'HAENS, G; GEBOES, K; PEETERS, M et al.The American journal of gastroenterology. 1997, Vol 92, Num 8, pp 1275-1279, issn 0002-9270Article

Proctitis and rectal stenosis induced by nonsteroidal antiinflammatory suppositoriesD'HAENS, G; BREYSEM, Y; RUTGEERTS, P et al.Journal of clinical gastroenterology. 1993, Vol 17, Num 3, pp 207-212, issn 0192-0790Article

A phase II randomized study of Combined Infusional Leucovorin Sodium and 5-FU versus the Leucovorin Calcium followed by 5-FU both in combination with Irinotecan or Oxaliplatin in patients with metastatic colorectal cancerBLEIBERG, H; VANDEBROEK, A; DELEU, I et al.Acta gastro-enterologica belgica (English ed.). 2012, Vol 75, Num 1, pp 16-23, issn 1784-3227, 8 p.Article

Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's diseaseDE GREEF, E; HOFFMAN, I; ARTS, W et al.Acta gastro-enterologica belgica (English ed.). 2012, Vol 75, Num 4, pp 425-431, issn 1784-3227, 7 p.Article

Prevention of opportunistic infections in patients with inflammatory bowel disease and implications of the ECCO consensus in BelgiumRAHIER, J. F; MOREELS, T; DE MUNTER, P et al.Acta gastro-enterologica belgica (English ed.). 2010, Vol 73, Num 1, pp 41-45, issn 1784-3227, 5 p.Article

Treatment of Zenker's diverticulum through a flexible endoscope with a transparent oblique-end hood attached to the tip and a monopolar forcepsCHRISTIAENS, P; DE ROOCK, W; VAN OLMEN, A et al.Endoscopy (Stuttgart). 2007, Vol 39, Num 2, pp 137-140, issn 0013-726X, 4 p.Article

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitisTILG, H; VOGELSANG, H; D'HAENS, G et al.Gut. 2003, Vol 52, Num 12, pp 1728-1733, issn 0017-5749, 6 p.Article

A positive response to infliximab in Crohn disease: Association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphismLOUIS, E; VERMEIRE, S; MALAISE, M et al.Scandinavian journal of gastroenterology. 2002, Vol 37, Num 7, pp 818-824, issn 0036-5521, 7 p.Article

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's diseaseD'HAENS, G; GEBOES, K; PONETTE, E et al.Gastroenterology (New York, NY. 1943). 1997, Vol 112, Num 5, pp 1475-1481, issn 0016-5085Article

Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitisD'HAENS, G. R; LASHNER, B. A; HANAUER, S. B et al.The American journal of gastroenterology. 1993, Vol 88, Num 8, pp 1174-1178, issn 0002-9270Article

Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel diseasePEETERMANS, W. E; D'HAENS, G. R; CEUPPENS, J. L et al.Gastroenterology (New York, NY. 1943). 1995, Vol 108, Num 1, pp 75-82, issn 0016-5085Article

Massive intra-hepatic and extra-hepatic bile cast formation after cholecystectomyD'HAENS, G. R; RUCHIM, M. A; GOLDBERG, M. J et al.Gastrointestinal endoscopy. 1993, Vol 39, Num 4, pp 579-581, issn 0016-5107Article

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's diseasePANACCIONE, R; COLOMBEL, J.-F; SANDBORN, W. J et al.Alimentary pharmacology & therapeutics. 2010, Vol 31, Num 12, pp 1296-1309, issn 0269-2813, 14 p.Article